178 related articles for article (PubMed ID: 36647121)
1. Post-therapy plasma concentrations of quetiapine in Taiwanese patients.
Huang CY; Lin YF; Chen CR; Lin SK
Neuropsychopharmacol Rep; 2023 Mar; 43(1):50-56. PubMed ID: 36647121
[TBL] [Abstract][Full Text] [Related]
2. Effect of quetiapine and norquetiapine on anxiety and depression in major psychoses using a pharmacokinetic approach: a prospective observational study.
Altamura AC; Moliterno D; Paletta S; Buoli M; Dell'osso B; Mauri MC; Bareggi SR
Clin Drug Investig; 2012 Mar; 32(3):213-9. PubMed ID: 22299714
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics, tolerability, and clinical effectiveness of quetiapine fumarate: an open-label trial in adolescents with psychotic disorders.
McConville BJ; Arvanitis LA; Thyrum PT; Yeh C; Wilkinson LA; Chaney RO; Foster KD; Sorter MT; Friedman LM; Brown KL; Heubi JE
J Clin Psychiatry; 2000 Apr; 61(4):252-60. PubMed ID: 10830145
[TBL] [Abstract][Full Text] [Related]
4. The safety and pharmacokinetics of quetiapine when coadministered with haloperidol, risperidone, or thioridazine.
Potkin SG; Thyrum PT; Alva G; Bera R; Yeh C; Arvanitis LA
J Clin Psychopharmacol; 2002 Apr; 22(2):121-30. PubMed ID: 11910256
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic tolerance and rebound psychosis during quetiapine maintenance monotherapy in patients with schizophrenia and schizoaffective disorder.
Margolese HC; Chouinard G; Beauclair L; Bélanger MC
J Clin Psychopharmacol; 2002 Aug; 22(4):347-52. PubMed ID: 12172332
[TBL] [Abstract][Full Text] [Related]
6. Open-label study of the effect of combination quetiapine/lithium therapy on lithium pharmacokinetics and tolerability.
Potkin SG; Thyrum PT; Bera R; Carreon D; Alva G; Kalali AH; Yeh C
Clin Ther; 2002 Nov; 24(11):1809-23. PubMed ID: 12501876
[TBL] [Abstract][Full Text] [Related]
7. Switching from quetiapine to ziprasidone: a sixteen-week, open-label, multicenter study evaluating the effectiveness and safety of ziprasidone in outpatient subjects with schizophrenia or schizoaffective disorder.
Karayal ON; Glue P; Bachinsky M; Stewart M; Chappell P; Kolluri S; Cavus I
J Psychiatr Pract; 2011 Mar; 17(2):100-9. PubMed ID: 21430488
[TBL] [Abstract][Full Text] [Related]
8. A multicenter, randomized, double-blind, placebo-controlled, 16-week study of adjunctive aripiprazole for schizophrenia or schizoaffective disorder inadequately treated with quetiapine or risperidone monotherapy.
Kane JM; Correll CU; Goff DC; Kirkpatrick B; Marder SR; Vester-Blokland E; Sun W; Carson WH; Pikalov A; Assunção-Talbott S
J Clin Psychiatry; 2009 Oct; 70(10):1348-57. PubMed ID: 19906340
[TBL] [Abstract][Full Text] [Related]
9. Clinical predictors of acute response with quetiapine in psychotic mood disorders.
Zarate CA; Rothschild A; Fletcher KE; Madrid A; Zapatel J
J Clin Psychiatry; 2000 Mar; 61(3):185-9. PubMed ID: 10817103
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the relative safety, efficacy, and tolerability of quetiapine and risperidone in outpatients with schizophrenia and other psychotic disorders: the quetiapine experience with safety and tolerability (QUEST) study.
Mullen J; Jibson MD; Sweitzer D
Clin Ther; 2001 Nov; 23(11):1839-54. PubMed ID: 11768836
[TBL] [Abstract][Full Text] [Related]
11. Dose-response and comparative efficacy and tolerability of quetiapine across psychiatric disorders: a systematic review of the placebo-controlled monotherapy and add-on trials.
Zhornitsky S; Potvin S; Moteshafi H; Dubreucq S; Rompré PP; Stip E
Int Clin Psychopharmacol; 2011 Jul; 26(4):183-92. PubMed ID: 21372722
[TBL] [Abstract][Full Text] [Related]
12. The effect of multiple doses of cimetidine on the steady-state pharmacokinetics of quetiapine in men with selected psychotic disorders.
Strakowski SM; Keck PE; Wong YW; Thyrum PT; Yeh C
J Clin Psychopharmacol; 2002 Apr; 22(2):201-5. PubMed ID: 11910267
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of quetiapine in elderly patients with selected psychotic disorders.
Jaskiw GE; Thyrum PT; Fuller MA; Arvanitis LA; Yeh C
Clin Pharmacokinet; 2004; 43(14):1025-35. PubMed ID: 15530131
[TBL] [Abstract][Full Text] [Related]
14. Long-term safety, tolerability, and clinical efficacy of quetiapine in adolescents: an open-label extension trial.
McConville B; Carrero L; Sweitzer D; Potter L; Chaney R; Foster K; Sorter M; Friedman L; Browne K
J Child Adolesc Psychopharmacol; 2003; 13(1):75-82. PubMed ID: 12804128
[TBL] [Abstract][Full Text] [Related]
15. Quetiapine alone and added to a mood stabilizer for serious mood disorders.
Sajatovic M; Brescan DW; Perez DE; DiGiovanni SK; Hattab H; Ray JB; Bingham CR
J Clin Psychiatry; 2001 Sep; 62(9):728-32. PubMed ID: 11681770
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of quetiapine and risperidone against depressive symptoms in outpatients with psychosis.
Sajatovic M; Mullen JA; Sweitzer DE
J Clin Psychiatry; 2002 Dec; 63(12):1156-63. PubMed ID: 12523876
[TBL] [Abstract][Full Text] [Related]
17. Antipsychotic treatment in child and adolescent first-episode psychosis: a longitudinal naturalistic approach.
Castro-Fornieles J; Parellada M; Soutullo CA; Baeza I; Gonzalez-Pinto A; Graell M; Paya B; Moreno D; de la Serna E; Arango C
J Child Adolesc Psychopharmacol; 2008 Aug; 18(4):327-36. PubMed ID: 18759642
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and tolerability of extended-release quetiapine fumarate in Han Chinese patients with schizophrenia.
Li Q; Su YA; Liu Y; Chen JX; Tan YL; Yang FD; Si TM
Clin Pharmacokinet; 2014 May; 53(5):455-65. PubMed ID: 24385309
[TBL] [Abstract][Full Text] [Related]
19. Quetiapine for insomnia in Parkinson disease: results from an open-label trial.
Juri C; Chaná P; Tapia J; Kunstmann C; Parrao T
Clin Neuropharmacol; 2005; 28(4):185-7. PubMed ID: 16062098
[TBL] [Abstract][Full Text] [Related]
20. Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trial.
Pagsberg AK; Jeppesen P; Klauber DG; Jensen KG; Rudå D; Stentebjerg-Olesen M; Jantzen P; Rasmussen S; Saldeen EA; Lauritsen MG; Bilenberg N; Stenstrøm AD; Nyvang L; Madsen S; Werge TM; Lange T; Gluud C; Skoog M; Winkel P; Jepsen JRM; Fagerlund B; Correll CU; Fink-Jensen A
Lancet Psychiatry; 2017 Aug; 4(8):605-618. PubMed ID: 28599949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
